|
Meyenburg Cancer Research Prize
The Meyenburg Prize is awarded for outstanding achievements in cancer research by the Meyenburg Foundation in support of the German Cancer Research Center, Heidelberg (DKFZ), which is the largest biomedical research institution in Germany. The prize has been awarded annually since 1981, and currently has an honorarium of €50,000. List of Recipients SourceMeyenburg Award Winners * 1981 Werner W. Franke * 1982/1983 Holger Kirchner and * 1984 Lutz Gissmann * 1985 Volker Sturm * 1986 Karin Mölling * 1987 Mary Osborn * 1988 Elisabeth Gateff * 1989 * 1990 * 1991 Hans-Georg Rammensee * 1992 Walter Birchmeier * 1993 Johannes Gerdes * 1994 * 1995 David P. Lane * 1996 Peter H. Krammer * 1997 Patrick S. Moore and Yuan Chang * 1998 Richard D. Wood * 1999 Carl-Henrik Heldin * 2000 Matthias Mann * 2001 * 2002 Andrew Fire * 2004 Erich A. Nigg * 2005 Thomas Tuschl * 2006 Elizabeth Blackburn * 2007 Shinya Yamanaka * 2008 Hans Clevers * 2009 Brian Druker * 2010 Alan Ashworth * ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
German Cancer Research Center
The German Cancer Research Center (known as the Deutsches Krebsforschungszentrum or simply DKFZ in German) is a national cancer research center based in Heidelberg, Germany. It is a member of the Helmholtz Association of German Research Centres, the largest scientific organization in Germany. History The establishment of a national cancer research center in Germany was initiated by Heidelberg surgeon . The DKFZ was set up in 1964 by resolution of the State government of Baden-Württemberg as a foundation under public law. In 1975, the Center became a member of the Association of National Research Centers ("Arbeitsgemeinschaft der Großforschungseinrichtungen") which was transformed into the Hermann von Helmholtz Association of National Research Centers in 1995. The Center has also been a member of the Deutsche Forschungsgemeinschaft (DFG) since 1977. Two scientists to date that were affiliated with the DKFZ have received Nobel Prizes. The first was Harald zur Hausen who won th ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Carl-Henrik Heldin
Carl-Henrik Heldin (born 9 August 1952) is Chairman of the Board for the Nobel Foundation, and a molecular biologist and medical researcher. He has been director of the Uppsala branch of Ludwig Cancer Research since 1986 and professor in molecular cell biology at the medical faculty of Uppsala University since 1992. He is vice-president of the European Research Council since 2011 and was appointed chairman of the Nobel Foundation in 2013. His research has focused on the mechanisms of signal transduction by growth regulatory factors like platelet-derived growth factor (PDGF) and transforming growth factor (TGF). He was senior editor of Cancer Research from 2003 to 2009.CURRICULUM VITAE Academica Europaea. Retrieved 22 September 2013(pdf) Membership in Learned societies and Doctor honoris cau ...
|
Peter Campbell (scientist)
Peter Campbell may refer to: People * Patrick Campbell (1684–1751), also known as Peter Campbell, British Army General and Member of Parliament * Peter Campbell (Australian footballer, born 1875) (1875–1948), Australian rules footballer for Carlton * Peter Campbell (Australian footballer, born 1938), Australian rules footballer for Geelong * Peter Campbell (golfer) (born 1985), Canadian professional golfer * Peter Campbell (Greenock Morton footballer) (1875–1948), Scottish footballer (Greenock Morton, Burton Swifts and Scotland) * Peter Campbell (naval officer) (1780–c. 1832), founded the Uruguayan Navy * Peter Campbell (Rangers footballer) (1857–1883), Scottish footballer (Rangers, Blackburn Rovers and Scotland) * Peter Campbell (tennis) (born 1950), Australian tennis player * Peter Campbell (water polo) (born 1960), American water polo player * Peter Walter Campbell (1926–2005), gay English Conservative Party libertarian * Peter J. Campbell (1857–1919), American lawy ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Nathanael Gray
Nathanael S. Gray is a Krishnan-Shah Family Professor of chemical and systems biology at Stanford University and director of cancer therapeutics programme at Stanford University School of Medicine. Previously he was a Nancy Lurie Marks Professor of biological chemistry and molecular pharmacology at Harvard Medical School and professor of cancer biology at Dana–Farber Cancer Institute. Gray is also co-founder, science advisory board member (SAB) and equity holder in C4 Therapeutics, Gatekeeper, Syros, Petra, B2S, Aduro, Jengu, Allorion, Inception Therapeutics, and Soltego (board member). C4 Therapeutics, which offered IPO in 2020, was founded based on the ground-breaking research of Jay Bradner, current president of Novartis Institutes for BioMedical Research (NIBR), and of Nathanael S. Gray, while he was professor at Harvard Medical School. Before moving to Stanford University, Nathanael S. Gray created Center for Protein Degradation at Harvard Medical School with $80 million ag ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Charles Mullighan
Charles is a masculine given name predominantly found in English and French speaking countries. It is from the French form ''Charles'' of the Proto-Germanic name (in runic alphabet) or ''*karilaz'' (in Latin alphabet), whose meaning was "free man". The Old English descendant of this word was '' Ċearl'' or ''Ċeorl'', as the name of King Cearl of Mercia, that disappeared after the Norman conquest of England. The name was notably borne by Charlemagne (Charles the Great), and was at the time Latinized as ''Karolus'' (as in ''Vita Karoli Magni''), later also as '' Carolus''. Some Germanic languages, for example Dutch and German, have retained the word in two separate senses. In the particular case of Dutch, ''Karel'' refers to the given name, whereas the noun ''kerel'' means "a bloke, fellow, man". Etymology The name's etymology is a Common Germanic noun ''*karilaz'' meaning "free man", which survives in English as churl (< Old English ''ċeorl''), which developed its depre ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Stefan Hell
Stefan Walter Hell HonFRMS (: born 23 December 1962) is a Romanian-German physicist and one of the directors of the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany. He received the Nobel Prize in Chemistry in 2014 "for the development of super-resolved fluorescence microscopy", together with Eric Betzig and William Moerner. Life Born into a Roman Catholic Banat Swabian family in Arad, Romania, he grew up at his parents' home in nearby Sântana. Hell attended primary school there between 1969 and 1977. Andreea Pocotila"Fizicianul premiat cu Nobelul pentru chimie vorbește românește și ține legătura cu mediul științific din țara noastră" ''România Liberă'', October 8, 2014 Subsequently, he attended one year of secondary education at the Nikolaus Lenau High School in Timișoara before leaving with his parents to West Germany in 1978. His father was an engineer and his mother a teacher; the family settled in Ludwigshafen after emigrating. He ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Alan Ashworth
Alan Ashworth, FRS (born 1960 in Bolton, Lancashire) is a British molecular biologist, noted for his work on genes involved in cancer susceptibility. He is currently the President of the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, a multidisciplinary research and clinical care organisation that is one of the largest cancer centres in the Western United States. He was previously CEO of the Institute of Cancer Research (ICR) in London. Early life Ashworth was educated at St Mary's Primary School and Thornleigh Salesian College, Bolton. He completed his Bachelor of Science in Chemistry and Biochemistry at Imperial College, London, and was awarded a PhD in Biochemistry at University College, London. Career Ashworth joined the Institute for Cancer Research (ICR) in London in 1986 as a Postdoctoral research Scientist in the Section of Cell and Molecular Biology and in 1999 he was appointed the first Director of the Breakthrou ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Brian Druker
Brian J. Druker (born April 30, 1955) is a physician-scientist at Oregon Health & Science University, in Portland, Oregon. He is the director of OHSU's Knight Cancer Institute, Jeld-Wen Chair of Leukemia Research, and professor of medicine. In 2009, he won the Lasker-DeBakey Clinical Medical Research Award and the Meyenburg Award for his influential work in the development of imatinib for the treatment of chronic myeloid leukemia (CML). He has been called "Oregon's best-known scientist". Education Druker earned both his B.S. degree in chemistry and M.D. degree from the University of California, San Diego. He completed internship and residency in internal medicine at Barnes Hospital, Washington University School of Medicine in St. Louis from 1981 to 1984. Teaching and research Druker was a fellow in medical oncology at Dana–Farber Cancer Institute, Harvard Medical School, from 1984 to 1987. He began working at Oregon Health & Science University (OHSU) in 1993. In May 2007, ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Hans Clevers
Johannes (Hans) Carolus Clevers (born 27 March 1957) is a Dutch Molecular genetics, molecular geneticist, Cell biology, cell biologist and stem cell researcher. He became the Head of Pharma, Research and Early Development, and a member of the Corporate Executive Committee, of the Switzerland, Swiss healthcare company Roche in 2022. Previously, he headed a research group at the Royal Netherlands Academy of Arts and Sciences#Research institutes, Hubrecht Institute for Developmental Biology and Stem Cell Research and at the ; he remained as an advisor and guest scientist or visiting researcher to both groups. He is also a Professor in Molecular Genetics at the University of Utrecht. Early life and education Hans Clevers was born in Eindhoven, the Netherlands in 1957. He began studying biology at the University of Utrecht in 1975, but also started taking medicine in 1978, in part due to his interest and in part because his friends and brothers were in the medical profession. He spe ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Shinya Yamanaka
is a Japanese stem cell researcher and a Nobel Prize laureate. He serves as the director of Center for iPS Cell (induced Pluripotent Stem Cell) Research and Application and a professor at the Institute for Frontier Medical Sciences at Kyoto University; as a senior investigator at the UCSF-affiliated Gladstone Institutes in San Francisco, California; and as a professor of anatomy at University of California, San Francisco (UCSF). Yamanaka is also a past president of the International Society for Stem Cell Research (ISSCR). He received the 2010 BBVA Foundation Frontiers of Knowledge Award in the biomedicine category, the 2011 Wolf Prize in Medicine with Rudolf Jaenisch, and the 2012 Millennium Technology Prize together with Linus Torvalds. In 2012, he and John Gurdon were awarded the Nobel Prize for Physiology or Medicine for the discovery that mature cells can be converted to stem cells. In 2013, he was awarded the $3 million Breakthrough Prize in Life Sciences for his work. ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Elizabeth Blackburn
Elizabeth Helen Blackburn, (born 26 November 1948) is an Australian-American Nobel laureate who is the former president of the Salk Institute for Biological Studies. Previously she was a biological researcher at the University of California, San Francisco, who studied the telomere, a structure at the end of chromosomes that protects the chromosome. In 1984, Blackburn co-discovered telomerase, the enzyme that replenishes the telomere, with Carol W. Greider. For this work, she was awarded the 2009 Nobel Prize in Physiology or Medicine, sharing it with Greider and Jack W. Szostak, becoming the first Australian woman Nobel laureate. She also worked in medical ethics, and was controversially dismissed from the Bush administration's President's Council on Bioethics. Early life and education Elizabeth Helen Blackburn, one of seven children, was born in Hobart, Tasmania, on 26 November 1948 to parents who were both family physicians. Her family moved to the city of Launceston when ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Thomas Tuschl
Thomas Tuschl (born June 1, 1966) is a German biochemist and molecular biologist, known for his research on RNA. Biography Tuschl was born in Altdorf bei Nürnberg. After graduating in Chemistry from Regensburg University, Tuschl received his PhD in 1995 from the Max Planck Institute for Experimental Medicine in Göttingen. He spent four years as a post-doctoral fellow at the Whitehead Institute of the Massachusetts Institute of Technology (MIT) in Cambridge, USA. In 1999 he returned to Göttingen, to continue his research at the Max Planck Institute for Biophysical Chemistry. There he received international recognition in Genetics for his studies of RNA interference in collaboration with the laboratory of Klaus Weber. This enables "switching off" certain genes by introducing synthetic short RNA into the cell. The mRNA is destroyed and the gene in deactivated. Possible future applications of this method include treatment of tumors or genetic disorders. The function of certain ge ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
